(30.3 vs. 11.8 %, p < 0.05). At the molecular level, allicin treatment dose-dependently up-regulated claudin-4 expression both in vivo and in vitro (p < 0.05).
Conclusion: The findings indicate that allicin can protect against LPS-induced ALI in vivo and in vitro probably by up-regulation of claudin-4 expression.